Vland Biotech released its performance for the first three quarters, with a net profit attributable to the parent company of 61.78 million yuan, a year-on-year increase of 51.24%
According to the Zhitong Finance APP, Vland Biotech disclosed its third-quarter report for 2025, stating that the company achieved revenue of 1.016 billion yuan in the first three quarters, a year-on-year increase of 7.42%; net profit attributable to the parent company was 61.78 million yuan, a year-on-year increase of 51.24%; net profit excluding non-recurring items was 22.93 million yuan, a year-on-year decrease of 1.47%; basic earnings per share were 0.24 yuan
According to the Zhitong Finance APP, Vland Biotech (603739.SH) disclosed its third-quarter report for 2025. The company achieved revenue of 1.016 billion yuan in the first three quarters, a year-on-year increase of 7.42%; the net profit attributable to shareholders was 61.78 million yuan, a year-on-year increase of 51.24%; the net profit excluding non-recurring items was 22.93 million yuan, a year-on-year decrease of 1.47%; the basic earnings per share were 0.24 yuan
